Literature DB >> 6886428

Coating of liposomes with subunits of monoclonal IgM antibody and targeting of the liposomes.

Y Hashimoto, M Sugawara, H Endoh.   

Abstract

SH-bearing subunits of IgM antibody were coupled through the Fc portion to sonicated liposomes consisting of N-(m-maleimidobenzoyl)dipalmitoylphosphatidylethanolamine, dipalmitoylphosphatidylcholine and cholesterol. Liposomes coated with subunits of monoclonal IgM antibody against a mouse mammary tumor-associated antigen selectively bound to the antigenic target cells. Assays of the liposomes for complement dependent cytotoxicity and spleen cell binding revealed inactivation of the liposome-coupled antibodies in both assays.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886428     DOI: 10.1016/0022-1759(83)90242-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Selective gene therapy for prostate cancer cells using liposomes conjugated with IgM type monoclonal antibody against prostate-specific membrane antigen.

Authors:  Shusei Ikegami; Takushi Tadakuma; Kazuo Yamakami; Takeshi Ono; Satoshi Suzuki; Ichiro Yoshimura; Tomohiko Asano; Masamichi Hayakawa
Journal:  Hum Cell       Date:  2005-03       Impact factor: 4.174

2.  Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.

Authors:  S Suzuki; K Inoue; A Hongoh; Y Hashimoto; Y Yamazoe
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen.

Authors:  T Tanaka; S Suzuki; T Masuko; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1989-04

4.  Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.

Authors:  Claire Vanpouille-Box; François Hindré
Journal:  Front Oncol       Date:  2012-10-10       Impact factor: 6.244

5.  Cytotoxicity of anti-c-erbB-2 immunoliposomes containing doxorubicin on human cancer cells.

Authors:  S Suzuki; S Uno; Y Fukuda; Y Aoki; T Masuko; Y Hashimoto
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.